NAD+ Explained: What It Does, What It Doesn't, and What the Science Shows
NAD+ is a real cellular coenzyme with legitimate roles in energy and repair, but the anti-aging hype outpaces the evidence. Here's what research supports.
On this page · 7 sections
NAD+, or nicotinamide adenine dinucleotide, is a coenzyme present in nearly every cell of the body. It helps enzymes convert food into usable energy inside mitochondria, supports DNA repair, and works with proteins such as sirtuins and PARPs that maintain normal cell function. Because NAD+ levels tend to fall with age, it has attracted intense interest from researchers and wellness marketers alike.
The science is real, but the claims often are not. Here is a clear breakdown of what NAD+ does, what its precursors can and cannot do, and how to think about supplementation sensibly.
What NAD+ Actually Does in the Body
NAD+ acts as a molecular shuttle, moving electrons through the metabolic pathways that turn nutrients into ATP, the cell's energy currency. It also fuels enzymes involved in DNA repair, stress responses, and metabolic regulation. It is not a stimulant, does not act like caffeine, and cannot force energy production where the cell's machinery is already limited.
Why Levels Drop With Age
Several factors appear to drive the age-related decline: greater NAD+ use by DNA-repair and inflammatory pathways, reduced recycling of NAD+ building blocks, mitochondrial stress, metabolic disease, and possibly slower synthesis. Lower NAD+ availability may make energy generation sluggish, but aging involves far more than this one molecule.
What Research Actually Supports
Human studies confirm that oral precursors can raise NAD+ levels. Nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) have both been shown to increase NAD+ or related metabolites in clinical trials.
- A 2025 randomized trial in long-COVID patients found NR raised NAD+ within five weeks but did not significantly improve objective cognitive scores compared with placebo. Exploratory results hinted at possible fatigue, sleep, and mood benefits that need larger studies.
- A small trial of NMN in women with overweight and prediabetes showed improved muscle insulin response and signaling.
- A 2024 systematic review of NMN trials concluded it is generally well tolerated, with nonsignificant gains in some physical performance measures.
The credible areas of interest remain cellular energy metabolism, mitochondrial function, insulin sensitivity, fatigue-related states, and possibly some neurologic or cognitive applications.
What the Evidence Does Not Support
NAD+ therapy has not been proven to reverse aging or cure Alzheimer's disease, Parkinson's disease, cancer, chronic fatigue syndrome, long-COVID, addiction, or metabolic disease. Subjective reports of feeling better are real for some people, but they do not equate to proven clinical benefit. For many people, poor sleep, overtraining, low protein intake, insulin resistance, thyroid issues, anemia, depression, medications, alcohol, or chronic inflammation are far more important drivers of fatigue than NAD+ status.
Delivery Methods Compared
IV Infusions
IV NAD+ is marketed as premium and medical-grade, bypassing the gut to enter the bloodstream directly. Because NAD+ is a charged molecule, however, simply raising blood levels does not guarantee better cellular uptake. Human pharmacokinetic data remain limited, and tolerability and infusion characteristics are still being studied.
Subcutaneous Injections
Some clinicians use subcutaneous NAD+, but high-quality human outcome data are sparse. Dosing, absorption, and tissue effects all need better research.
Oral NR and NMN
Oral NR and NMN currently have the most practical evidence for raising NAD+-related metabolites. They are easier to use, less expensive, and better studied than clinic-based injectables. Recent FDA positioning confirmed NMN is not categorically excluded from dietary supplement status, though New Dietary Ingredient compliance still applies.
What to Realistically Expect
Some people report better energy, mental clarity, exercise tolerance, or recovery within weeks. Others notice subtle changes over 8–12 weeks. Many notice nothing at all. A reasonable trial period for oral NR or NMN is 8–12 weeks, ideally paired with objective tracking: sleep quality, recovery, fasting glucose or insulin markers, body composition, and energy levels. If nothing changes, continuing is hard to defend.
Safety and Who Should Be Cautious
NR and NMN appear generally well tolerated in short-term studies. Reported side effects include nausea, flushing, headache, digestive upset, fatigue, insomnia, and changes in methylation-related metabolites, depending on dose and formulation. Long-term safety data are still limited.
People who should approach supplementation with medical supervision include those who are pregnant or breastfeeding, people with active cancer or those on chemotherapy or radiation, patients with severe liver or kidney disease, individuals with bipolar disorder or severe anxiety, and anyone on complex medication regimens.
The cancer question warrants special caution. NAD+ supports normal cellular repair, but cancer cells also rely on NAD+ pathways. It does not mean NAD+ causes cancer, but high-dose strategies should not be used casually in anyone with active malignancy.
The Bottom Line
NAD+ is real biology, not just wellness hype, yet the marketing around it frequently overstates what it can do. Oral precursors like NR and NMN can raise NAD+-related markers, and the molecule plays a legitimate role in cellular energy and resilience. What remains unproven is any claim that it reverses aging, cures disease, or delivers dramatic overnight transformation.
For the right person, NAD+ support may be a reasonable addition, but it works best as one piece of a broader plan that includes strength training, adequate sleep, sufficient protein, metabolic health, and a medical workup for any underlying causes of persistent fatigue.
